Oncology Peer Review On-The-Go: 1-on-1 With Richard L. Schilsky, MD, on Molecular Profiling in GI Cancers
Schilsky joined CancerNetwork®’s podcast to discuss ASCO’s Advance of the Year, the top priorities moving forward, and the COVID-19 pandemic.
This week, CancerNetwork® sat down for a one-on-one conversation with former Chief Medical Officer and Executive Vice President of the American Society for Clinical Oncology, Richard L. Schilsky, MD, to discuss ASCO’s 2021 “Advance of the Year,” molecular profiling in gastrointestinal cancers.
Schilsky discussed the progress being made in this field and the top research contributing to the momentum in gastrointestinal cancers, while also elaborating on health equity in cancer research, ASCO’s top research priorities moving forward, and more.
He also explained the changes forced on clinical trials due to the COVID-19 pandemic, and how he anticipates trials can leverage these adjustments moving forward in a post-COVID world.
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
![Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F55a279b707f0cd71181a5efa8b3d3cd864555701-3002x1684.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].")
